Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1985;71:1179-1190

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lytle, B. W.
Right arrow Articles by Loop, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lytle, B. W.
Right arrow Articles by Loop, F. D.

Circulation, Vol 71, 1179-1190, Copyright © 1985 by American Heart Association


ARTICLES

Mitral valve replacement combined with myocardial revascularization: early and late results for 300 patients, 1970 to 1983

BW Lytle, DM Cosgrove, CC Gill, RW Stewart, LA Golding, M Goormastic, PC Taylor and FD Loop

Of 300 consecutive patients undergoing primary operation for mitral valve replacement combined with coronary bypass grafting, 22 (7.3%) died in-hospital. Multivariate testing of preoperative and operative descriptors identified radiographic cardiac enlargement, preoperative paced rhythm or atrial fibrillation, 70% or more left main coronary obstruction, and serum bilirubin of more than 2 mg% as factors associated with an increase in in-hospital mortality. Follow-up of the 278 hospital survivors (mean interval 48 months, range 2 to 165 months) documented survival of 85%, 66%, and 31% and an event-free survival of 65%, 46%, and 21% at 2, 5, and 10 postoperative years, respectively. Cox proportional-hazard regression models of late risk implicated in- hospital ventricular arrhythmias, left ventricular dysfunction, and rheumatic or ischemic causes of mitral valve disease in decreasing long- term survival. In addition, patients with bioprostheses without warfarin anticoagulation had better survival and event-free survival than those with bioprostheses taking warfarin and those with mechanical prostheses with or without warfarin.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker
Ischemic Mitral Regurgitation
Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802.
[Full Text]


Home page
Card Surg AdultHome page
M. LeBoutillier III and V. J. DiSesa
Valvular and Ischemic Heart Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 1175 - 1192.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. F. Ibrahim, D. Paparella, J. Ivanov, M. R. Buchanan, and S. J. Brister
Gender-related differences in morbidity and mortality during combined valve and coronary surgery
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 959 - 964.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. C. Gorman, J. H. Gorman III, and L. H. Edmunds Jr.
Ischemic Mitral Regurgitation
Card. Surg. Adult, January 1, 2003; 2(2003): 751 - 769.
[Full Text]


Home page
Card Surg AdultHome page
M. LeBoutillier III and V. J. DiSesa
Valvular and Ischemic Heart Disease
Card. Surg. Adult, January 1, 2003; 2(2003): 1057 - 1074.
[Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. G. Seipelt, F. A. Schoendube, J. F. Vazquez-Jimenez, H. Doerge, M. Voss, and B. J. Messmer
Combined mitral valve and coronary artery surgery: ischemic versus non-ischemic mitral valve disease
Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. H. Thourani, W. S. Weintraub, J. M. Craver, E. L. Jones, J. P. Gott, W. M. Brown III, J. D. Puskas, and R. A. Guyton
Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery
Ann. Thorac. Surg., September 1, 2000; 70(3): 778 - 783.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B. Iung
VALVE DISEASE: Interface between valve disease and ischaemic heart disease
Heart, September 1, 2000; 84(3): 347 - 352.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. H. Thourani, W. S. Weintraub, J. M. Craver, E. L. Jones, E. M. Mahoney, and R. A. Guyton
Ten-year trends in heart valve replacement operations
Ann. Thorac. Surg., August 1, 2000; 70(2): 448 - 455.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Izhar, R. C. Daly, J. A. Dearani, T. A. Orszulak, H. V. Schaff, and C. J. Mullany
Mitral Valve Replacement or Repair After Previous Coronary Artery Bypass Grafting
Circulation, November 9, 1999; 100(90002): II-84 - 89.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. G. Duarte, Y. Shen, M. J. MacDonald, E. L. Jones, J. M. Craver, and R. A. Guyton
Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone: late results
Ann. Thorac. Surg., August 1, 1999; 68(2): 426 - 430.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. J. Flameng, P. Herijgers, J. Szecsi, P. T. Sergeant, W. J. Daenen, and I. Scheys
Determinants of Early and Late Results of Combined Valve Operations and Coronary Artery Bypass Grafting
Ann. Thorac. Surg., February 1, 1996; 61(2): 621 - 628.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G.-W. He, T. E. Acuff, W. H. Ryan, R. T. Bowman, M. B. Douthit, and M. J. Mack
Determinants of operative mortality in elderly patients undergoing coronary artery bypass grafting: Emphasis on the influence of internal mammary artery grafting on mortality and morbidity
J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 73 - 81.
[Abstract] [Full Text]